AstraZeneca, FDA curb access to cancer drug Iressa

WASHINGTON (Reuters) - AstraZeneca Plc said on Friday it severely limited access to its lung cancer drug, Iressa, after U.S. health officials agreed with studies showing it did not help patients live longer.

Continue to AstraZeneca, FDA curb access to cancer drug Iressa on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz